T/CADERM 3050-2023 狂犬病被动免疫制剂使用规范

ICS11.020

CCSC05

团体标准

T/CADERM3050-2023

狂犬病被动免疫制剂使用规范

Specificationforuseofrabiespassiveimmunizationpreparation

2023-12-6发布2024-1-6实施

中国医学救援协会发布

T/CADERM3050—2023

目次

前言............................................................................II

引言...........................................................................III

1范围.................................................................................1

2规范性引用文件.......................................................................1

3术语和定义...........................................................................1

4适应证和使用时机.....................................................................2

4.1适应证...........................................................................2

4.2使用时机.........................................................................2

5使用剂量.............................................................................2

5.1概述.............................................................................2

5.2狂犬病人免疫球蛋白（HRIG）使用剂量...............................................2

5.3抗狂犬病血清（ERIG）使用剂量.....................................................2

5.4抗狂犬病病毒单克隆抗体使用剂量...................................................3

6使用方法.............................................................................2

6.1浸润注射方法.....................................................................2

6.2被动免疫制剂不足以浸润注射全部伤口时使用方法.....................................3

6.3特殊部位伤口的使用方法...........................................................3

6.4黏膜暴露时使用方法...............................................................3

6.5狂犬病被动免疫制剂使用要求.......................................................3

7过程记录.............................................................................3

7.1病历或护理记录................................